Evidence map›Paper›PMID 37188843›Full record

ArticleJournal of molecular modeling2023

Theoretical study of cis-trans isomer of 2-hydroxy-5-methyl-2'-nitroazobenzene: DFT insight.

Fernando Nainggolan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Fernando NainggolanDepartment of Chemical Engineering, Politeknik Teknologi Kimia Industri, Medan, Indonesia. fernando.nainggolan@ptki.ac.id.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe synthesis of azobenzene materials is an important aspect of the research in the field of photo-switch materials. It is currently thought that azobenzene molecules exist in the cis and trans form of molecular structure configuration. However, the reaction process allowing for reversible energy switches from trans to cis form is still challenging. Therefore, it is crucial to understand the molecular properties of the azobenzene compounds in order to provide reference for future synthesis and application. Affirmation supporting this perspective has been substantially derived from theoretical results in the isomerization process and whether these molecular structures may affect the electronic properties entirely needs to be confirmed. In this study, I give my effort to understand the molecular structure properties of the cis and trans form of azobenzene molecule from 2-hydroxy-5-methyl-2'-nitroazobenzene (HMNA). Their chemistry phenomena are investigated using the density functional theory (DFT) method. This study shows that the trans-HMNA has a molecular size of 9.0 Å and the cis-HMNA has a molecular size of 6.6 Å. The trans-HMNA exhibits an electronic transition of π → π* type driven by an azo bond, whereas the cis-HMNA exhibits an electronic transition of n → π* type with respect to the non-bonding electrons of oxygen and nitrogen atoms. Therefore, the HMNA mechanism pathway from trans to cis form is feasible to undergo at the inversion pathway in the ground state.

methodsAll DFT calculations were performed using the Gaussian Software Packages (Gaussian 09 Revision-A.02 and GaussView 5.0.8). Gaussum 3.0 software was selected to visualize the molecular orbital levels in the density of states diagram. The optimized molecular geometrical parameter was calculated using B3LYP/cc-pVTZ level in the gas phase. TD-DFT with M06-2X/cc-pVTZ level was used as a method for the precise interpretation of excited states in molecular systems.

Indexed as

AzobenzeneDFTIsomerStructure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.